Liver cirrhosis, caused by long-term liver damage, is estimated to affect around 100 million people worldwide
News
Bio-Rad and Oncocyte partner to develop and commercialise transplant monitoring products
Solid organ transplantation is used to treat end-stage organ failure, including the kidneys
Francis Crick researchers reveal pathways linking intestinal inflammation and colitis
Affecting over 500,000 people in the UK, IBD comprises Crohn’s disease and ulcerative colitis
Nine UCL researchers secure £560m in research funding from ERC
Approximately 14% of the competition-submitted proposals were selected to receive funding
KCL and McMaster University partner to advance nuclear medicine research
Both partners’ will leverage their nuclear research facilities and expertise to develop new health interventions
Study suggests tumour microenvironments could predict cancer progression
NSCLC is the most common type of lung cancer and is responsible for up to 85% of all cases
Researchers call to reduce repeat antibiotic prescriptions for respiratory tract infections
RTIs account for around 60% of global antibiotic prescribing and are a key driver of AMR
UK study finds screening with a PSA test in prostate cancer can lead to overdiagnosis
Prostate cancer is responsible for around 12,000 deaths a year in the UK and is the second biggest cause of death for men
Study reveals shorter scans for prostate cancer could improve diagnosis
The most common form of cancer in men is responsible for 12,000 deaths every year in the UK
Bio-Rad and Alleghany Health Network partner for patients with solid tumour cancer
Solid tumour cancers account for 90% of adult human cancers and 50% of childhood malignancies
US researchers reveal positive results of personalised vaccine for liver cancer
Hepatocellular carcinoma is one of the leading causes of cancer-related deaths worldwide
Culmination Bio and BillionToOne partner to advance cancer diagnosis
Both will validate the clinical performance of two new diagnostic tests for regulatory submission
Alliance Healthcare launches cancer symptom referral scheme in UK pharmacies
Macmillan Cancer Support estimated that around three million people in the UK were living with cancer in 2022
Unitaid funds over £6m to Liverpool researchers to treat major diseases
The project aims to advance therapeutics for tuberculosis, malaria and hepatitis C in LMICs
Key mechanism controlling bone marrow stem cells could lead to new therapies
Hoxa9 and b-catenin molecules are a rare population of self-renewing HSCs found in bone marrow
